医学
导管内乳头状粘液性肿瘤
相伴的
内科学
胰腺
入射(几何)
发育不良
胃肠病学
前瞻性队列研究
人口
无症状的
胰腺导管腺癌
相对风险
累积发病率
自然史
胰腺癌
糖尿病
放射科
胰腺切除术
腺癌
囊肿
优势比
绝对风险降低
置信区间
过度诊断
急性胰腺炎
并发症
外科
作者
Noboru Ideno,Masafumi Nakamura,Toshifumi Kin,Mamoru Takenaka,Kazuo Hara,Tetsuya Takikawa,Yousuke Nakai,Shinsuke Koshita,Keiji Hanada,Kentaro Sudo,Hiroyuki Uehara,Satoshi Tanno,Hiroki Oyama,Shinya Uemura,Junya Gibo,Toru Maruo,Kazuyuki Matsumoto,Teru Kumagi,Toyoma Kaku,Yoshio Sogame
标识
DOI:10.1097/sla.0000000000007255
摘要
OBJECTIVE: To evaluate the natural history, especially concomitant pancreatic ductal adenocarcinoma (cPDAC) risk in patients with branch-duct intraductal papillary mucinous neoplasm (BD-IPMN) without worrisome features (WF) or high-risk stigmata (HRS). SUMMARY BACKGROUND DATA: BD-IPMNs without WF/HRS are considered low-risk, yet optimal surveillance strategies remain uncertain. METHODS: In a prospective multicenter Japan Pancreas Society registry, 1234 patients with BD-IPMN without WF/HRS underwent imaging and laboratory surveillance every 6 months for up to 5.17 years. Cumulative incidence, standardized incidence ratios (SIRs), and competing-risk analyses were performed to assess advanced pancreatic neoplasia, defined as IPMN high-grade dysplasia (IPMN-HGD), invasive IPMN, or cPDAC, and associated risk factors. Outcomes were also evaluated under simulated guideline-recommended extended surveillance intervals. RESULTS: During 5.17 years of follow-up, advanced pancreatic neoplasia developed in 26 patients: 10 IPMN-HGD/invasive IPMN and 16 cPDAC. The 5.17-year cumulative incidence was 2.48%; SIRs relative to the general population were 8.01 overall, 3.07 for IPMN-HGD/invasive IPMN, and 4.91 for cPDAC. The cPDAC SIRs were 6.21 and 3.02 for cysts <20 mm and ≥20 mm, respectively. Diabetes history and mural nodule development predicted IPMN-HGD/invasive IPMN, whereas CA19-9 elevation and new or worsening diabetes predicted cPDAC. Of 19 patients eligible for surveillance interval extension, 13 (68%) had a later simulated detection date. CONCLUSION: Patients with BD-IPMN without WF/HRS at baseline had 3.07 and 4.91 times the incidences of IPMN-HGD/invasive IPMN and cPDAC expected in the general population, respectively. Surveillance based solely on cyst stability may warrant caution regarding the timely detection of surgically resectable pancreatic cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI